Short-Term Course Of Budesonide May Lead To Clinical Remission In Around 80% Of Patients With Lymphocytic Colitis, Study Suggests
Source: Lymphocytic Colitis Responds Rapidly to Budesonide | Medpage Today
Douglas Lowe II MD is Board Certified in Gastroenterology by the American Board of Internal Medicine
Douglas Lowe II MD
Douglas Lowe II MD is a Board Certified Gastroenterologist with Southern Gastroenterology Specialists
